Clinical trial Recruiting at 1 site Interventional Ages 13 to 18

Group skills training for youth at risk of psychosis

Official title: Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis

Run by University of Pittsburgh · NCT05398120 · Data updated 2026-11-12

This study is trying out a group program that teaches important skills to help teens and young adults at risk of psychosis feel better and manage their stress.

More Psychological trials

Quick facts

Study typeInterventional
Ages13 Years to 18 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedApril 26, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 10, 2026
Trial IDNCT05398120 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 13-18 who meet criteria for clinical high-risk for psychosis and are enrolled in the HOPE team at the University of Pittsburgh.

Probably not a fit

Patients with a current or past diagnosis of a psychotic disorder will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the feasibility of a group intervention that combines cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills for adolescents and young adults at clinical high-risk for psychosis. Participants aged 13-18, who are already receiving services from the HOPE team at the University of Pittsburgh, will attend weekly 90-minute sessions for 15 weeks. The sessions will focus on mindfulness, stress management, self-disturbance improvement, and social skills development. Data will be collected to assess the feasibility and potential outcomes of this integrated approach.

Why it matters

Potential benefit: If successful, this intervention could provide effective skills training to help at-risk youth manage symptoms and improve functioning.

How similar studies have gone: While this approach is exploratory, similar interventions combining CBT and DBT have shown promise in other populations, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participant Inclusion Criteria:

* 13-18 years of age
* Meet criteria for clinical high-risk syndrome (i.e., at clinical high risk for developing a psychotic disorder). CHR status is determined based off of scoring a 3 (moderate) - 5 (severe) on the Structured Interview for Psychosis-Risk Syndromes and/or having a first degree relative with psychotic disorder and/or the individual meets criteria for schizotypal personality disorder. Additionally individuals with a brief intermittent psychotic symptoms can be included as well (e.g., frankly psychotic symptoms that are very brief)
* Individuals must be enrolled in the HOPE team at the University of Pittsburgh since this group is embedded within that service

Participation Exclusion Criteria:

* Group member meeting criteria for a current/past psychotic disorder

Inclusion Criteria for Parents or Legal Guardians:

* Must be the parent, legal guardian of a 13-18 year-old
* For parents of CHR adolescents, their adolescent must meet criteria for a psychosis-risk syndrome

Where it's running

  • Bellefield Towers
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Leslie Horton, PhD — University of Pittsburgh
  • Study coordinator: Tina Gupta, PHD
  • Email: guptat3@upmc.edu
  • Phone: 412-246-5845

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.